Shrieve Chemical Company

Overview

Deal Type Mergers & Acquisitions
Corporate Banking
Client & Transactional Partners Shrieve Chemical Company
Gemspring Capital
Our Role Exclusive Sell-Side Advisor

Summary

On December 2, 2019, KeyBanc Capital Markets (“KBCM”) successfully completed the sale of a majority interest in Shrieve Chemical Company, LLC (“Shrieve”) to Gemspring Capital (“Gemspring”).

KBCM was chosen to serve as exclusive sell-side advisor based on its expertise within the industrial distribution and chemicals sectors, relationship with Shrieve and proven M&A execution capabilities.

Recent Deals

July 2025

kodiak

a portfolio company of

courtsquare

divested

kodiak partner

to a

Private Investor Consortium

Exclusive Sell-Side Advisor

kodiak-interiors-group-llc
July 2025

beacon

acquired

ascension borgess

from

ascension

Financial Advisor

beacon-health
July 2025

a portfolio company of 

and

$1.815 Billion

Senior Secured Credit Facilities

$900 Million

8.50% First Lien Secured Notes due 2032

Joint Lead Arranger
Joint Bookrunner

radiology-partners
June 2025

allied

$245 Million

Senior Secured Credit Facilities

Debt Advisor

allied

Connect With Us

Find an Expert